Home/Pipeline/Tretinoin Gel

Tretinoin Gel

Dermatology

PreclinicalActive

Key Facts

Indication
Dermatology
Phase
Preclinical
Status
Active
Company

About Avecho Biotechnology

Australiancho leverages a vitamin‑E‑based delivery platform to boost efficacy and tolerability of diverse health products.

View full company profile

Other Dermatology Drugs

DrugCompanyPhase
Not specified in provided content3SbioVarious
Dermatology CandidatesAucta PharmaceuticalsNot Specified
PCI for Nucleic Acid DeliveryPCI BiotechPreclinical
Undisclosed Transcription Factor ProgramMontai TherapeuticsDevelopment Candidate (DC) expected 2026
Undisclosed Biologic Replacement ProgramMontai TherapeuticsDevelopment Candidate (DC) expected 2027